Rare diseases
Investigational molecules
Locations
Back to Germany840 clinical trials in Oldenburg In Holstein, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Phase 2/3 Randomized Study of SKY-0515 for Safety and Efficacy in Adults with Huntington’s Disease
GermanyA Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus
GermanyPhase II study of autologous enriched T‑cell therapy expressing CD19 and CD22 CARs in Philadelphia‑negative B‑precursor ALL patients with measurable residual disease
GermanyStudy of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia
GermanyPhase 3 Study of Taletrectinib as Adjuvant Therapy in Patients with Completely Resected ROS1‑Positive Stage IB‑IIIA Non‑Small Cell Lung Cancer
GermanyLong‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
GermanyColchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients
GermanyShortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo
GermanyA study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis
GermanyA Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma
GermanyStudy of Izalontamab Brengitecan versus Platinum-based Chemotherapy for Patients with EGFR-mutated Non-small Cell Lung Cancer after EGFR Inhibitor Treatment
GermanyStudy to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Type 2 Diabetes management and treatments, including studies of novel weekly insulin alternatives and oral medications for glycemic control.
Multiple studies evaluating new therapeutic approaches for better diabetes management and reducing cardiovascular risks.
Comprehensive research into obesity treatment and weight-related conditions, examining new therapeutic combinations and their effects on weight loss and associated health conditions.
Studies focusing on innovative approaches to weight management and treating obesity-related health complications.
Research examining treatments for atherosclerotic cardiovascular disease and related conditions, with emphasis on preventing major adverse cardiovascular events.
Trials evaluating new medications for improving cardiovascular outcomes in high-risk patients.
Clinical investigations of treatments for Crohn's Disease and other digestive conditions, focusing on long-term efficacy and safety of new therapeutic approaches.
Studies aimed at improving quality of life for patients with chronic gastrointestinal conditions.
Advanced studies in colorectal cancer treatment and management, including innovative approaches to Stage II and III cancer therapy.
Trials evaluating new treatment strategies for improving outcomes in cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
